OraCOV

N/A

Report date: 2025/01/26 16:00:57

Base Information

Drug NameOraCOV
Drug Alias NameSARS-CoV2 prophylactic vaccine (Sanaria/Protein Potential/Institute for Tropical Medicine Tübingen)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitute for Tropical Medicine Tübingen
China Registration ClassN/A

Develop Information

Active CompaniesProtein Potential LLCInstitute for Tropical Medicine TübingenSanaria Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A